ADVISORY: Media Briefing on the Disease-fighting Promise of mRNA
Johns Hopkins MedicineResearchers are studying messenger RNA鈥檚 potential to treat and prevent an array of serious conditions鈥攊ncluding cancer.
Researchers are studying messenger RNA鈥檚 potential to treat and prevent an array of serious conditions鈥攊ncluding cancer.
By analyzing DNA and proteins in the blood of people with and without acute spinal cord injuries (SCIs), researchers at the Johns Hopkins University School of Medicine have developed a novel blood test that has the potential to rapidly predict severity and likelihood of sensory and motor recovery within six months in a cost-effective manner.
A study led by Johns Hopkins Medicine researchers could advance the development of new drugs that block or open such signaling channels to treat conditions as varied as epilepsy and some intellectual disorders.
Gabryelle 鈥淕abby鈥 Scholfield, a 16-year-old student-athlete at Edmondson Westside High School in Baltimore, who plays center on her basketball team, is known for getting rebounds on the basketball court. However, only about a year ago, she was rebounding from serious complications of multiple sclerosis (MS).
Two researchers from the Johns Hopkins University School of Medicine have been elected 2024 Fellows of the American Association for the Advancement of Science (AAAS), the largest scientific society in the world and publisher of the Science family of journals.
In the spring, the grass turns green, trees begin to bud and flowers blossom again. However, the change in season also can bring runny and stuffy noses, sneezes and itchy, watery eyes.
Scientists from Johns Hopkins Medicine and eight other institutions in the United States, Africa and Europe say they have identified a potential new gene target that could be edited to treat sickle cell disease, an inherited blood disorder marked by sickle-shaped red blood cells that cause intense pain and shorten lifespans.
Johns Hopkins Medicine scientists say they have shed new light on how bacteria protect themselves from certain phage invaders 鈥 by seizing genetic material from weakened, dormant phages and using it to 鈥渧accinate鈥 themselves to elicit an immune response.
In a recent, cross-institutional study partially funded by the National Institutes of Health, researchers report that healthy human airways are at higher risk for dehydration and inflammation when exposed to dry air, an occurrence expected to increase due to global warming.
Johns Hopkins Children鈥檚 Center pediatric infectious diseases specialists Aaron Milstone, M.D., M.H.S., and Erica Prochaska, M.D., M.H.S., M.H.S., are available to discuss the following topics related to measles.
A novel analysis of more than 375 published studies concluded that the association between chronic pain and rates of depression and anxiety is staggering. The study, led by investigators at Johns Hopkins Medicine found that 40% of adults with chronic pain experienced 鈥渃linically significant depression and anxiety.鈥 Among those most at risk, the analysis showed, were women, younger adults and people with fibromyalgia.
Johns Hopkins University engineers have developed a pioneering prosthetic hand that can grip plush toys, water bottles, and other everyday objects like a human, carefully conforming and adjusting its grasp to avoid damaging or mishandling whatever it holds.
Johns Hopkins Medicine laboratory scientists say they have developed a potential new way to treat a variety of rare genetic diseases marked by too low levels of specific cellular proteins. To boost those proteins, they鈥檝e created experimental versions of a genetic 鈥渢ail鈥 that attaches to so-called mRNA molecules that churn out the proteins.
Audacy鈥檚 36th annual Mix 106.5 Radiothon last week raised $1,141,307.64 for Johns Hopkins Children鈥檚 Center. The final total was announced on Mix 106.5 (WWMX-FM) on Monday, March 3. During the event, Mix 106.5 broadcast live from the Children鈥檚 Center for a total of 26 hours.
New research, led by Johns Hopkins Children鈥檚 Center investigators and sponsored by the National Institutes of Health鈥檚 (NIH) National Institute of Allergy and Infectious Diseases (NIAID), finds that omalizumab, a U.S. Food and Drug Administration-approved (FDA) injectable drug for food allergies, performed better than oral immunotherapy. A subsequent phase of the study also found that patients may be able to introduce allergenic foods into their diets after stopping the medicine.
A new study of hundreds of patient records has added to evidence that it鈥檚 likely best to use as little corticosteroid medicine as possible when treating people who have lupus, a common heart complication of the autoimmune disorder.
A bone marrow transplant process co-developed by investigators at the Johns Hopkins Kimmel Cancer Center is safe and curative for adults with sickle cell disease, according to results of a trial completed at Johns Hopkins and about 20 additional cancer centers nationwide and in London.
Johns Hopkins researchers say they found that infection with a common virus that can be transmitted from mother to fetus before birth significantly worsens an often-fatal complication of premature birth called necrotizing enterocolitis (NEC) in experiments with mice.
March is Colorectal Cancer Awareness Month. Experts from Johns Hopkins Medicine are available to discuss the importance of regular screenings for early detection.
What:聽Audacy鈥檚 36th annual Mix 106.5 radiothon benefiting Johns Hopkins Children鈥檚 Center kicks off Thursday, Feb. 27, and ends Friday, Feb. 28. The radiothon, the Children鈥檚 Center鈥檚 largest fundraising event of the year, airs on the Baltimore radio station throughout the two days.聽